|
"yen c j"的相關文件
顯示項目 356-380 / 471 (共19頁)
<< < 10 11 12 13 14 15 16 17 18 19 > >>
每頁顯示[10|25|50]項目
| 國立成功大學 |
2020 |
Phase I dose-escalation and -expansion study of telisotuzumab (ABT-700), an Anti-c-met antibody, in patients with advanced solid tumors
|
Strickler, J.H.;LoRusso, P.;Salgia, R.;Kang, Y.-K.;Yen, C.J.;Lin, C.-C.;Ansell, P.;Motwani, Motwani M.;Wong, S.;Yue, H.;Wang, L.;Reilly, E.;Afar, D.;Naumovski, L.;Ramanathan, Ramanathan R.K. |
| 國立成功大學 |
2020 |
Safety and Preliminary Efficacy of Ramucirumab in Combination with FOLFOX4 in Patients with Advanced Hepatocellular Carcinoma: A Nonrandomized, Open-Label, Phase Ib Study
|
Lin, C.-C.;Yang, T.-S.;Yen, C.-J.;Cheng, R.;Liu, J.;Hsu, C. |
| 國立成功大學 |
2020 |
Dishevelled 1-Regulated Superpotent Cancer Stem Cells Mediate Wnt Heterogeneity and Tumor Progression in Hepatocellular Carcinoma
|
Liao, W.-Y.;Hsu, C.-C.;Chan, T.-S.;Yen, C.-J.;Chen, W.-Y.;Pan, H.-W.;Tsai, K.K. |
| 國立成功大學 |
2020 |
Multicentre, phase II study of gemcitabine and S-1 in patients with advanced biliary tract cancer: TG1308 study
|
Chiang, N.-J.;Chen, M.-H.;Yang, S.-H.;Hsu, C.;Yen, C.-J.;Tsou, H.-H.;Su, Y.-Y.;Chen, J.-S.;Shan, Y.-S.;Chen, L.-T. |
| 臺大學術典藏 |
2019 |
Old age is a positive modifier of renal outcome in Taiwanese patients with stages 3-5 chronic kidney disease
|
Chou Y.-H.;Yen C.-J.;Lai T.-S.;Yung-Ming Chen; Chou Y.-H.; Yen C.-J.; Lai T.-S.; YUNG-MING CHEN |
| 臺大學術典藏 |
2019 |
Old age is a positive modifier of renal outcome in Taiwanese patients with stages 3–5 chronic kidney disease
|
Chen Y.-M.; TAI-SHUAN LAI; Chou Y.-H.; Yen C.-J. |
| 臺大學術典藏 |
2019 |
Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
|
Lu L.-C.; CHIUN HSU; Shao Y.-Y.; Chao Y.; Yen C.-J.; Shih I.-L.; Hung Y.-P.; Chang C.-J.; Shen Y.-C.; Guo J.-C.; Liu T.-H.; Hsu C.-H.; Cheng A.-L. |
| 國立成功大學 |
2019 |
Effect of First-line S-1 Plus Oxaliplatin with or Without Ramucirumab Followed by Paclitaxel Plus Ramucirumab on Advanced Gastric Cancer in East Asia: The Phase 2 RAINSTORM Randomized Clinical Trial
|
Yoshikawa, T.;Muro, K.;Shitara, K.;Oh, D.-Y.;Kang, Y.-K.;Chung, H.C.;Kudo, T.;Chin, K.;Kadowaki, S.;Hamamoto, Y.;Hironaka, S.;Yoshida, K.;Yen, C.-J.;Omuro, Y.;Bai, L.-Y.;Maeda, K.;Ozeki, A.;Yoshikawa, R.;Kitagawa, Y. |
| 國立成功大學 |
2019 |
Oral hygiene and the overall survival of head and neck cancer patients
|
Chang, Chang C.-C.;Lee, W.-T.;Hsiao, J.-R.;Ou, C.-Y.;Huang, C.-C.;Tsai, S.-T.;Chen, K.-C.;Huang, J.-S.;Wong, T.-Y.;Lai, Y.-H.;Wu, Y.-H.;Hsueh, W.-T.;Wu, S.-Y.;Yen, C.-J.;Chang, J.-Y.;Lin, C.-L.;Weng, Y.-L.;Yang, H.-C.;Chen, Y.-S.;Chang, J.S. |
| 國立成功大學 |
2019 |
A nationwide survey of adherence to analgesic drugs among cancer patients in Taiwan: prevalence, determinants, and impact on quality of life
|
Chou, W.-C.;Chen, J.-S.;Hung, C.-Y.;Lu, C.-H.;Shao, Y.-Y.;Chiou, T.-J.;Sung, Y.-C.;Rau, K.-M.;Yen, C.-J.;Yeh, S.-P.;Liu, T.-C.;Wu, M.-F.;Lee, M.-Y.;Yu, M.-S.;Hwang, W.-L.;Lai, P.-Y.;Chang, Chang C.-S.;Hsieh, R.-K. |
| 國立成功大學 |
2019 |
Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
|
Lu, Lu L.-C.;Hsu, C.;Shao, Y.-Y.;Chao, Y.;Yen, C.-J.;Shih, I.-L.;Hung, Y.-P.;Chang, Chang C.-J.;Shen, Y.-C.;Guo, J.-C.;Liu, T.-H.;Hsu, C.-H.;Cheng, A.-L. |
| 國立成功大學 |
2019 |
A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma
|
Qin, S.;Chan, S.L.;Sukeepaisarnjaroen, W.;Han, G.;Choo, S.P.;Sriuranpong, V.;Pan, H.;Yau, T.;Guo, Y.;Chen, M.;Ren, Z.;Xu, J.;Yen, C.-J.;Lin, Z.-Z.;Manenti, L.;Gu, Y.;Sun, Y.;Tiedt, R.;Hao, L.;Song, W.;Tanwandee, Tanwandee T. |
| 國立成功大學 |
2019 |
Patients with head and neck cancer may need more intensive pain management to maintain daily functioning: a multi-center study
|
Cho, S.-F.;Rau, K.-M.;Shao, Y.-Y.;Yen, C.-J.;Wu, M.-F.;Chen, J.-S.;Chang, Chang C.-S.;Yeh, S.-P.;Chiou, T.-J.;Hsieh, R.-K.;Lee, M.-Y.;Sung, Y.-C.;Lee, K.-D.;Lai, P.-Y.;Yu, M.-S.;Hwang, W.-L.;Liu, T.-C. |
| 國立成功大學 |
2019 |
Generation of a heterozygous p53 R249S mutant human embryonic stem cell line by TALEN-mediated genome editing
|
Huo, Z.;Tu, J.;Xu, A.;Li, Y.;Wang, D.;Liu, M.;Zhou, R.;Zhu, D.;Lin, Y.;Gingold, J.A.;Yen, C.-J.;Xiao, H.;Zhao, R. |
| 國立成功大學 |
2019 |
The influence of prediagnosis alcohol consumption and the polymorphisms of ethanol-metabolizing genes on the survival of head and neck cancer patients
|
Lee, W.-T.;Hsiao, J.-R.;Ou, C.-Y.;Huang, C.-C.;Chang, Chang C.-C.;Tsai, S.-T.;Chen, K.-C.;Huang, J.-S.;Wong, T.-Y.;Lai, Y.-H.;Wu, Y.-H.;Hsueh, W.-T.;Wu, S.-Y.;Yen, C.-J.;Chang, J.-Y.;Lin, C.-L.;Weng, Y.-L.;Yang, H.-C.;Chen, Y.-S.;Chang, J.S. |
| 國立成功大學 |
2019 |
Validation of Alcohol Flushing Questionnaire to Identify ALDH2 Status in a Case–Control Study of Head and Neck Cancer
|
Hsiao, J.-R.;Lee, W.-T.;Ou, C.-Y.;Huang, C.-C.;Chang, Chang C.-C.;Tsai, S.-T.;Chen, K.-C.;Huang, J.-S.;Wong, T.-Y.;Lai, Y.-H.;Wu, Y.-H.;Hsueh, W.-T.;Wu, S.-Y.;Yen, C.-J.;Chang, J.-Y.;Lin, C.-L.;Weng, Y.-L.;Yang, H.-C.;Chen, Y.-S.;Chang, J.S. |
| 國立成功大學 |
2019 |
Maintenance avelumab versus continuation of first-line chemotherapy in gastric cancer: JAVELIN Gastric 100 study design
|
Moehler, Moehler M.;Ryu, M.-H.;Dvorkin, M.;Lee, K.-W.;Coşkun, H.Ş.;Wong, R.;Chung, H.C.;Poltoratsky, A.;Tsuji, A.;Yen, C.J.;Muntean, A.S.;Le, Sourd S.;Vaccaro, G.M.;Overton, L.;Boku, N.;Wainberg, Z.A.;Patel, M.;Sharma, M.;Xiong, H.;Conti, I.;Taieb, J.;Bang, Y.-J. |
| 國立成功大學 |
2019 |
Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
|
Zhu, A.X.;Kang, Y.-K.;Yen, C.-J.;Finn, R.S.;Galle, P.R.;Llovet, J.M.;Assenat, E.;Brandi, G.;Pracht, M.;Lim, H.Y.;Rau, K.-M.;Motomura, K.;Ohno, I.;Merle, P.;Daniele, B.;Shin, D.B.;Gerken, Gerken G.;Borg, C.;Hiriart, J.-B.;Okusaka, T.;Morimoto, Morimoto M.;Hsu, Y.;Abada, P.B.;Kudo, M.;investigators, REACH-2 study |
| 國立成功大學 |
2019 |
First-in-human phase i study of fisogatinib (BLU-554) validates aberrant FGF19 signaling as a driver event in hepatocellular carcinoma
|
Kim, R.D.;Sarker, D.;Meyer, T.;Yau, T.;Macarulla, T.;Park, J.-W.;Choo, S.P.;Hollebecque, A.;Sung, M.W.;Lim, H.-Y.;Mazzaferro, V.;Trojan, J.;Zhu, A.X.;Yoon, J.-H.;Sharma, Sharma S.;Lin, Z.-Z.;Chan, S.L.;Faivre, S.;Feun, L.G.;Yen, C.-J.;Dufour, J.-F.;Palmer, D.H.;Llovet, J.M.;Manoogian, Manoogian M.;Tugnait, M.;Stransky, N.;Hagel, M.;Kohl, N.E.;Lengauer, C.;Sherwin, C.A.;Schmidt-Kittler, O.;Hoeflich, K.P.;Shi, H.;Wolf, B.B.;Kang, Y.-K. |
| 臺大學術典藏 |
2018-09-10T18:03:32Z |
Effect of Kidney Dysfunction on Cerebral Cortical Thinning in Elderly Population
|
Chen, C.-H. ; Chen, Y.-F. ; Chiu, M.-J. ; Chen, T.-F. ; Tsai, P.-H. ; Chen, J.-H. ; Yen, C.-J. ; Tang, S.-C. ; Yeh, S.-J. ; Chen, Y.-C.; YEN-CHING CHEN; YA-FANG CHEN; CHUNG-JEN YEN |
| 臺大學術典藏 |
2018-09-10T09:41:36Z |
A rare and under-recognized pathogen in peritoneal dialysis peritonitis: Corynebacterium jeikeium
|
Chao, C. T.;Huang, J. W.;Yen, C. J.; Chao, C.T. and Huang, J.W. and Yen, C.J.; 嚴崇仁 ;趙家德 ;黃政文; CHUNG-JEN YEN; Chao, C. T.; CHIA-TER CHAO; Huang, J. W.; JENQ-WEN HUANG; Yen, C. J. |
| 臺大學術典藏 |
2018-09-10T09:39:43Z |
High peritoneal KT/V and peritonitis rates are associated with peritoneal calcification.
|
Huang, J.W.;Lien, Y.C.;Yang, C.Y.;Liu, K.L.;Fang, C.C.;Wu, C.K.;Lee, J.K.;Wu, H.Y.;Chiang, C.K.;Cheng, H.T.;Yen, C.J.;Hung, K.Y.; CHIH-KANG CHIANG |
| 臺大學術典藏 |
2018-09-10T08:29:49Z |
Prevalence of geriatric conditions: A hospital-wide survey of 455 geriatric inpatients in a tertiary medical center
|
Chen, C.C.H. Yen, C.-J. Dai, Y.-T. Wang, C. Huang, G.-H.Chen, C.C-H.; Yen, C.J.; Dai, Y.T.; Wang, Charlotte.; Huang, G.H ;Chen, Cheryl Chia-Hui;Yen, Chung-Jen;Dai, Yu-Tzu;Huang, Guan-Hua; CHERYL CHIA-HUI CHEN; Chen, C.C-H.; Yen, C.J.; CHUNG-JEN YEN; YU-TZU DAI; Dai, Y.T.; Wang, Charlotte.; CHEN, CHERYL CHIA-HUI; Huang, G.H; YEN, CHUNG-JEN; DAI, YU-TZU; HUANG, GUAN-HUA |
| 臺大學術典藏 |
2018-09-10T08:21:00Z |
Life expectancy, expected years of life lost and survival of hemodialysis and peritoneal dialysis patients
|
Kao, T.-W.;Huang, J.-W.;Hung, K.-Y.;Chang, Y.-Y.;Chen, P.-C.;Yen, C.-J.;Chen, Y.-M.;Chu, T.-S.;Wu, M.-S.;Tsai, T.-J.;Wu, K.-D.;Wang, J.-D.; Pau-Chung CHEN |
| 臺大學術典藏 |
2018-09-10T08:17:36Z |
Shared risk factors for distinct geriatric syndromes in older Taiwanese inpatients
|
Chen, C.C.; Dai, Y.T.; Yen, C.J.; Huang, C.H.; Wang, Charlotte; Chen, C.C.-H. and Dai, Y.-T. and Yen, C.-J. and Huang, G.-H. and Wang, C.; CHERYL CHIA-HUI CHEN; Chen, C.C.; CHUNG-JEN YEN; Dai, Y.T.; YU-TZU DAI; Yen, C.J.; Huang, C.H.; Wang, Charlotte |
顯示項目 356-380 / 471 (共19頁)
<< < 10 11 12 13 14 15 16 17 18 19 > >>
每頁顯示[10|25|50]項目
|
